Top Markets
Coin of the day
BIOLASE, Inc. BIOLASE, Inc.

BIOLASE, Inc.

BIOL
Classement en actions #42643
BIOLASE, Inc., along with its various divisions, operates as a global... BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.
Prix de l'action
$0.00695
Dernière synchronisation: 2024-10-29
Capitalisation boursière
$536.40
Changement (1 jour)
-0.71%
Changement (1 an)
0.00%
Pays
US
Échange BIOLASE, Inc. (BIOL)

Catégorie

Ratio P/E pour BIOLASE, Inc. (BIOL)
Ratio P/E au August 2026 TTM : 0.00
Selon les derniers rapports financiers et le cours de l'action de BIOLASE, Inc., le ratio P/E actuel (TTM) est de 0.00. À la fin de l’année 2022, le P/E de l’entreprise était de -0.16.
Historique du ratio P/E pour BIOLASE, Inc. de 2000 à 2026
Ratio P/E à la fin de chaque année
Année Ratio P/E Changez
2026 (TTM) 0.00 -98.29%
2023 -0.07 -55.88%
2022 -0.16 -95.59%
2021 -3.57 133.74%
2020 -1.53 113.47%
2019 -0.71 -24.55%
2018 -0.95 -49.66%
2017 -1.88 -65.94%
2016 -5.53 129.22%
2015 -2.41 -61.44%
2014 -6.25 -26.96%
2013 -8.56 -57.80%
2012 -20.28 13.38%
2011 -17.89 365.23%
2010 -3.85 -77.06%
2009 -16.76 297.64%
2008 -4.22 -48.97%
2007 -8.26 -82.35%
2006 -46.80 316.41%
2005 -11.24 -3.09%
2004 -11.60 -159.36%
2003 19.54 -56.04%
2002 44.44 -115.29%
2001 -290.61 3,034.63%
2000 -9.27 0.00%
Ratio P/E pour des entreprises similaires ou concurrentes
Entreprise P/E Ratio Différence du P/E Ratio Pays
33.99 -2,832,358.33%
US
33.47 -2,789,583.33%
US
21.39 -1,782,416.67%
IE
18.84 -1,570,325.00%
US
49.47 -4,122,225.00%
US
Comment lire un P/E ratio ?

Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.

Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.

Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.